J. Marques, Vera L. M. Silva, Artur M. S. Silva, Mario Monteiro Marques, S. Braga
{"title":"钌(II)三噻吩环壬烷5-(2-羟基苯基)-3-[(4-甲氧基苯基)吡唑],一种易于合成且对PC-3和MDA-MB-231细胞具有高细胞毒性的配合物","authors":"J. Marques, Vera L. M. Silva, Artur M. S. Silva, Mario Monteiro Marques, S. Braga","doi":"10.1080/2164232X.2013.873992","DOIUrl":null,"url":null,"abstract":"The ruthenium(II) complex [Ru([9]aneS 3)(phpz)Cl 2] (1) ([9]aneS 3=trithiacyclononane, phpz=5-(2- hydroxyphenyl)-3-[(4-methoxystyryl)pyrazole]) was readily isolated by reacting [Ru([9]aneS 3)(DMSO)Cl 2] with one equivalent of the ligand phpz. A combination of MS, FT–IR and solution NMR studies (1-D and 2-D) was employed to determine the structural formula of the complex 1, in which phpz coordinates in a monodentate mode to Ru(II) by a simple replacement of the leaving group DMSO of the precursor. The cytotoxic properties of 1 in vitro were investigated by determination of the half-maximal growth inhibition on the human prostate (PC-3) and breast cancer cells (MDA-MB-231).","PeriodicalId":10590,"journal":{"name":"Complex Metals","volume":"1 1","pages":"12 - 7"},"PeriodicalIF":0.0000,"publicationDate":"2014-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"8","resultStr":"{\"title\":\"Ru(II) trithiacyclononane 5-(2-hydroxyphenyl)-3-[(4-methoxystyryl)pyrazole], a complex with facile synthesis and high cytotoxicity against PC-3 and MDA-MB-231 cells\",\"authors\":\"J. Marques, Vera L. M. Silva, Artur M. S. Silva, Mario Monteiro Marques, S. Braga\",\"doi\":\"10.1080/2164232X.2013.873992\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The ruthenium(II) complex [Ru([9]aneS 3)(phpz)Cl 2] (1) ([9]aneS 3=trithiacyclononane, phpz=5-(2- hydroxyphenyl)-3-[(4-methoxystyryl)pyrazole]) was readily isolated by reacting [Ru([9]aneS 3)(DMSO)Cl 2] with one equivalent of the ligand phpz. A combination of MS, FT–IR and solution NMR studies (1-D and 2-D) was employed to determine the structural formula of the complex 1, in which phpz coordinates in a monodentate mode to Ru(II) by a simple replacement of the leaving group DMSO of the precursor. The cytotoxic properties of 1 in vitro were investigated by determination of the half-maximal growth inhibition on the human prostate (PC-3) and breast cancer cells (MDA-MB-231).\",\"PeriodicalId\":10590,\"journal\":{\"name\":\"Complex Metals\",\"volume\":\"1 1\",\"pages\":\"12 - 7\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-03-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"8\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Complex Metals\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/2164232X.2013.873992\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Complex Metals","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/2164232X.2013.873992","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Ru(II) trithiacyclononane 5-(2-hydroxyphenyl)-3-[(4-methoxystyryl)pyrazole], a complex with facile synthesis and high cytotoxicity against PC-3 and MDA-MB-231 cells
The ruthenium(II) complex [Ru([9]aneS 3)(phpz)Cl 2] (1) ([9]aneS 3=trithiacyclononane, phpz=5-(2- hydroxyphenyl)-3-[(4-methoxystyryl)pyrazole]) was readily isolated by reacting [Ru([9]aneS 3)(DMSO)Cl 2] with one equivalent of the ligand phpz. A combination of MS, FT–IR and solution NMR studies (1-D and 2-D) was employed to determine the structural formula of the complex 1, in which phpz coordinates in a monodentate mode to Ru(II) by a simple replacement of the leaving group DMSO of the precursor. The cytotoxic properties of 1 in vitro were investigated by determination of the half-maximal growth inhibition on the human prostate (PC-3) and breast cancer cells (MDA-MB-231).